Skip to content

Non-Inferiority Study Comparing MINI WELL READY® and FineVision® in Patients With Cataract Surgery

A Multicentre, Controlled, Randomised, Single-blind, Two-armed Trial Evaluating the Visual Performance, Quality of Vision and Subjective Outcomes After Bilateral Implantation of MINI WELL Ready® or FineVision® in Patients With Cataract Surgery.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03060954
Enrollment
8
Registered
2017-02-23
Start date
2019-02-10
Completion date
2020-03-05
Last updated
2020-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Presbyopia

Brief summary

Interventional, Multicentre, controlled, randomized, single blind, twoarmed non-inferiority trial

Detailed description

To evaluate the non-inferiority of the progressive extended depth of focus Intraocular Lens MINI WELL READY® in terms of visual performance, quality of vision and subjective outcomes versus the trifocal Intraocular Lens FineVision® after a follow up period of 2-6 months.

Interventions

DEVICEMINI WELL READY ®

BILATERAL IMPLANTATION OF MINI WELL READY®, A PROGRESSIVE EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS IN PATIENTS WITH CATARACT SURGERY

DEVICEFINE VISION®

FINE VISION®, A TRIFOCAL INTRAOCULAR LENS IMPLANTATION IN PATIENTS WITH CATARACT SURGERY

Sponsors

Opera CRO, a TIGERMED Group Company
CollaboratorOTHER
SIFI SpA
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Bilateral cataract surgery required, no other ocular comorbidities * Healthy corneas, not treated surgically * Available for second-eye surgery within 1 week of the initial operation * Spherical refraction between -8.00D and +6.00D * Willing to adhere to the study visit schedule * Normal anterior and posterior segments * Clear intraocular media - other than cataract * To benefit from a social security system before being enrolled * Written informed consent consistent with local regulation research in human subjects

Exclusion criteria

* Any previous history of ocular trauma or prior ocular surgery (including previous cataract surgery and CLRIs) * Ocular comorbidities determining potential postoperative Visual Acuity less than 0.50 decimal (0.3 logMAR) * Expected to require retinal laser treatment * A history of retinal detachment or predisposition for such disorder * Psudoexfoliation * Abnormal pupil size and position * Pupil size \> 7 mm under mesopic condition * Use of contact lenses 30 days before the preoperative visit * Corneal warpage (e.g. Keratoconus, Pellucid Marginal Corneal Degeneration or Keratoglobus) * Corneal astigmatism greater than 0.75D * Zonular laxicity * Absence of adequate capsular support for the implant of the intraocular lens in the capsular bag * Microphthalmus * Active ocular disease in the operative eye, for example, chronic uveitis, proliferative diabetic retinopathy, chronic glaucoma unresponsive to medication, corneal decompensation and corneal endothelial cell insufficiency (such as Fuch's endothelial dystrophy) * Suspected microbial infection * Irregularities and capsulorexis decentralization * Surgical difficulties that may increase the risk of complications such as persistent bleeding, significant iris damage, an uncontrollable intraocular hypertonia, or damage due to significant vitreous loss * Patients in whom the intraocular lens may interfere with the ability to observe, diagnose or treat diseases of the posterior segment * Patients in whom neither the posterior capsule nor the zonula can provide adequate support to the lens * Subjects with any systemic disease that could increase operative risk or confound the outcome * Pregnant or lactating or planning a pregnancy at the time of enrolment * Vulnerable subjects (children \<18 years, people in guardianship or trusteeship or inability to give an informed consent) * Subjects participating in a concurrent clinical trial or if they have participated in an ophthalmology clinical trial within the last 30 days

Design outcomes

Primary

MeasureTime frameDescription
Defocus curve - binocular6 monthsDefocus curve assessment

Other

MeasureTime frameDescription
Visual Acuity Evaluation6 monthsUncorrected Distance Visual Acuity (UDVA)
Reading speed6 monthsReading speed performance
Halometry6 monthsHalos evaluation
Refraction6 monthsOcular refraction evaluation
Subject satisfaction questionnaire - VF-11R6 monthsSubject satisfaction questionnaire - VF-11R revised version: Annex A: Subject's glasses independence and light dependence Annex B: Quality of Vision (QoV) questionnaire
Operative Complications / Postoperative Complications / Adverse Event Assessment6 monthsAssessment of Operative Complications, Postoperative Complications, Adverse Events
Contrast sensitivity6 monthsContrast sensitivity evaluation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026